Session Type
Meeting
Search Results for Hepatic Encephalopathy
Abstract Number: 228
Hospital Medicine 2019, March 24-27, National Harbor, Md.
Background: Rifaximin 550 mg tablets is a nonsystemic antibiotic indicated for reducing the risk of overt hepatic encephalopathy (OHE) recurrence in adults and may be used alone or in combination with the cathartic lactulose. This analysis evaluated the safety profile of rifaximin alone vs rifaximin + lactulose (combination) in patients with cirrhosis. Methods: In a […]
Abstract Number: 331
Hospital Medicine 2018; April 8-11; Orlando, Fla.
Background: Rifaximin, a nonsystemic antibiotic, may be used alone or in combination with lactulose for reducing the risk of overt hepatic encephalopathy (OHE) recurrence in adults. This analysis evaluated rifaximin alone and rifaximin + lactulose (combination) on health-related quality of life (QOL) and caregiver burden in patients with a history of OHE. Methods: In a […]
Abstract Number: 341
Hospital Medicine 2019, March 24-27, National Harbor, Md.
Background: Hepatic encephalopathy (HE) is a common complication in patients with end stage liver disease. Variability in presentation can be a source of clinical uncertainty for medical providers. Ammonia levels have historically been used to aid in the diagnosis of HE despite low positive and negative predictive values. Our primary objective was to determine the […]
Abstract Number: 359
Hospital Medicine 2018; April 8-11; Orlando, Fla.
Background: Hepatic encephalopathy (HE) is a common neurological complication in patients with cirrhosis. In addition to numerous morbidity-related issues, HE is associated with substantial economic burden. Treatment includes lactulose or rifaximin, a nonsystemic antibiotic that is indicated for reducing the risk of overt HE recurrence in adults. Rifaximin has also been shown to reduce the […]
Abstract Number: 395
Hospital Medicine 2019, March 24-27, National Harbor, Md.
Background: Rifaximin 550 mg tablets is a nonsystemic antibiotic indicated for reducing the risk of overt hepatic encephalopathy (HE) recurrence in adults and may be used in combination with lactulose. Practice guidelines state that rifaximin is effective as add-on therapy to lactulose for preventing overt HE recurrence. This pooled analysis evaluated the efficacy and safety […]
Abstract Number: 567
Hospital Medicine 2018; April 8-11; Orlando, Fla.
Case Presentation: A 51-year-old woman presented with recurrent confusion and altered mental status over the past 6 months. She reported associated hallucinations, altered sleep cycle and hyper-arousal symptoms. She was treated with lactulose and rifaximin for suspected hepatic encephalopathy with no improvement. She denied any other symptoms. Past medical history was significant for cirrhosis secondary […]
Abstract Number: 605
Hospital Medicine 2018; April 8-11; Orlando, Fla.
Case Presentation: A hospitalized 71-year-old female became acutely encephalopathic after an esophagogastroduodenoscopy under conscious sedation which was performed to evaluate a chronic esophageal ulcer and other potential causes of dysphagia. Her past medical history was significant for obesity, hypothyroidism, chronic back pain, peripheral neuropathy, colorectal mucinous adenocarcinoma with carcinomatosis and metastases to the lung, chronic […]
Abstract Number: 652
Hospital Medicine 2020, Virtual Competition
Case Presentation: 74-year-old male with history of NASH cirrhosis with Grade I esophageal variceal bleeding history, SDH s/p burr hole drainage with course complicated by seizures on Keppra and Vimpat, type 2 diabetes mellitus, and coronary artery disease status post 1 drug eluting stent who presented with worsening confusion, fatigue and difficulty walking x 3-4 […]
Abstract Number: 712
SHM Converge 2021
Case Presentation: A 33-year-old female was initially admitted to the ICU for septic shock secondary to complicated Pseudomonas aeruginosa urinary tract infection and methicillin-sensitive Staphylococcus aureus bacteremia. CT of the abdomen showed fluid in the left paracolic gutter. Aspiration and culture of the fluid was positive for Staph aureus and attributed to seeding from bacteremia. […]
Abstract Number: 729
Hospital Medicine 2016, March 6-9, San Diego, Calif.
Case Presentation: A 30 year old woman with history of benign essential hypertension, hyperlipidemia, gastroesophageal reflux disease and fatty liver disease who was four days post-partum after a vaginal delivery complicated by post-partum depression presented with acute onset altered mentation, erratic behavior, visual hallucinations, combativeness and occasional bursts of hyperactivity. She had been started on […]